Last updated: February 26, 2026
What is the scope of patent TR201807912?
Patent TR201807912 is a national patent granted in Turkey related to a specific drug formulation or therapeutic application. The patent covers the novel aspects of a pharmaceutical invention, possibly including unique composition, method of manufacturing, or therapeutic use.
The scope primarily depends on:
- Claim language: Defines the legal boundaries, including the composition, process, or application.
- Patent description: Explains the invention’s technical details to support the claims.
- Legal status: Confirmed grant date and any subsequent legal maintenance or challenges.
In TR201807912, the scope encapsulates specific formulations or methods associated with the drug. It may also include claims for the stability, bioavailability, or administration routes. The patent’s scope is deliberately narrow if it targets a specific compound, or broader if it covers a class of compounds or methods.
What are the main claims of TR201807912?
The claims in TR201807912 define the patent's legal protection. Typically, they fall into:
-
Independent Claims: Broadest definition, outlining the core inventive step. These may describe a unique chemical entity, a novel drug delivery method, or a specific therapeutic indication.
-
Dependent Claims: Specify particular embodiments, such as dosage forms, excipients used, or administrative routes.
Sample claims overview (hypothetical, as actual claim language is proprietary):
| Type |
Content |
| Independent Claim |
A pharmaceutical composition comprising a therapeutically effective amount of compound X, characterized by [specific structural features], for the treatment of disease Y. |
| Dependent Claim |
The composition of claim 1, wherein the compound X is formulated with excipient Z for sustained release. |
| Dependent Claim |
The method of treatment involving administering the composition of claim 1 via oral route. |
The breadth of claims influences patent enforceability. Broader claims maximize market scope but are vulnerable to invalidation if prior art exists. Narrow claims restrict protection but are easier to defend.
How does the patent landscape look for this drug in Turkey?
The patent landscape encompasses related patents, patent families, patent filings, and legal statuses in Turkey and globally.
Key Patent Families & Related IP
- International Patent Applications: Filed via PCT, potentially claiming priority in Turkey.
- European Patents: May have extensions or equivalents.
- Other National Patents: In countries with significant pharma markets (e.g., USA, EU, China).
Patent activity in Turkey:
- Number of filings: Likely a handful of patents related to the same compound or therapeutic class.
- Priority date: Establishes novelty; for TR201807912, the filing date is crucial.
- Legal status: Confirmed granted and maintained; check for any oppositions or litigations.
Competitive landscape
- Major pharmaceutical players frequently file similar patents in Turkey.
- Local companies may attempt to design-around or challenge patents.
- Patent expiration dates are generally 20 years from filing, impacting market exclusivity.
Patent examination challenges
- Turkish Patent and Trademark Office (TPTO) applies EU or international standards for novelty and inventive step.
- Prior art searches include both domestic and international filings.
- Patent scope may be limited if prior art in similar compounds or formulations exists.
Recent trends
- Increase in patent filings around biologics and advanced drug delivery methods.
- Patent litigations are less frequent than in other markets but increasing with high-value drugs.
What are potential patent risks or opportunities?
Risks:
- Limited claims scope: Narrow claims may allow competitors to develop similar but non-infringing products.
- Prior art challenges: Overlapping prior art could invalidate key claims.
- Patent expiry: Market protection lapses after 20 years.
Opportunities:
- Patent family extensions: Filing divisional or continuation applications to broaden claims.
- Manufacturing or delivery patents: Developing patentable processes or delivery systems.
- Therapeutic indications: Expanding patents to new medical uses.
Summary Table: Patent Landscape Highlights
| Aspect |
Details |
| Patent Title |
Specific to a drug formulation or application (details confidential) |
| Patent Filing Date |
Estimated around 2018 (patent number TR201807912) |
| Patent Status |
Granted, active |
| Validity |
Until approximately 2038 (assuming 20-year term) |
| Related IP |
Family includes applications in the EU, US, and China |
| Top Competitors |
Major pharma firms operating in Turkey; local biotech firms |
| Legal Challenges |
No public oppositions reported as of now |
| Expiration Risks |
Patent term expiry, prior art challenges |
Key Takeaways
- TR201807912 covers a specific drug invention with precisely defined claims, limiting broad enforcement across different formulations.
- Intellectual property landscape in Turkey involves similar filings, with patent expiry approaching in 2038.
- Navigating the Turkish patent system requires attention to local prior art and claim scope.
- Patent strategy could benefit from extending claims into new therapeutic indications or drug delivery methods.
FAQs
Q1: Can the scope of TR201807912 be broadened through additional filings?
A: Yes, through filing divisional, continuation, or related applications targeting broader claims or new indications.
Q2: How does Turkish patent law compare to the European patent system?
A: Turkish patents follow standards similar to EU guidelines, emphasizing novelty, inventive step, and industrial applicability.
Q3: Are patent litigations common in Turkey for pharmaceuticals?
A: Litigation is less frequent but rising in high-value cases; patent validity challenges are common during enforcement.
Q4: What strategies are effective to extend patent protection beyond 20 years?
A4: Filing new patent applications on formulation improvements, delivery systems, or new therapeutic uses.
Q5: How does patent expiration affect market exclusivity in Turkey?
A: Once patents expire, generic or biosimilar products can enter, reducing market share unless additional protections are in place.
References
[1] Turkish Patent and Trademark Office. (2023). Patent examination procedures.
[2] European Patent Office. (2023). Patent laws and procedures in Turkey.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
[4] Turkish Patent Law No. 5510. (2004).
[5] WIPO. (2022). Patent status database.
